Implication of ultrasound bladder parameters on treatment response in patients with benign prostatic hyperplasia under medical management
作者机构:Department of UrologyGauhati Medical College HospitalGuwahatiAssamIndia
出 版 物:《Asian Journal of Urology》 (亚洲泌尿外科杂志(英文))
年 卷 期:2015年第2卷第4期
页 面:233-237页
学科分类:1002[医学-临床医学] 100210[医学-外科学(含:普外、骨外、泌尿外、胸心外、神外、整形、烧伤、野战外)] 10[医学]
主 题:Benign prostatic hyperplasia Uroflowmetry Tamsulosin Ultrasonography Prostatic urethral angle
摘 要:Objective:The prevalence of benign prostatic hyperplasia(BPH)rapidly increases after the 4th decade of *** combination of tamsulosin and dutasteride is a well established therapy for BPH of40 ***-invasive urodynamic parameters can predict the outcome of medical therapy in patients with *** aimed to correlate these parameters with treatment responses in BPH patients under medical ***:A prospective study was conducted in the Department of Urology in our hospital from May 2014 to April 2015.A total of 100 patients with BPH40 g who fulfilled our inclusion criteria were *** responses were determined by the International Prostate Symptom Score(IPSS)and *** ultrasonography with Doppler was performed to measure prostate volume,intravesical prostatic protrusion(IPP),detrusor wall thickness(DWT),the prostatic capsular artery resistive index(RI)and prostatic urethral angle(PUA)before and 3 months after combination therapy of tamsulosin and *** responses were correlated with non-invasive urodynamic ***:The IPSS,uroflow,age,prostate volume,RI,IPP,DWT and PUA were correlated before and after *** the 100 patients,70(70%)showed significant improvement and 30(30%)showed no improvement with ***:Ultrasound bladder parameters are useful tools for measuring the treatment response in BPH *** study shows that RI and DWT significantly correlate with the treatment response in BPH *** importantly,pretreatment values of increased IPP and PUA determines the non-improvement of symptoms in BPH *** study suggests the importance of transabdominal ultrasonography(KUBeP)with Doppler for evaluating treatment responses to medical management.